Mary T. Szela - Feb 13, 2024 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Role
CEO and President, Director
Signature
/s/ Mary Szela
Stock symbol
TLSI
Transactions as of
Feb 13, 2024
Transactions value $
$0
Form type
4
Date filed
11/25/2025, 03:55 PM
Previous filing
Aug 15, 2023
Next filing
Jun 7, 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Szela Mary T CEO and President, Director 6272 W. 91ST AVENUE, WESTMINSTER /s/ Mary Szela 2025-11-25 0001410289

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +125K +64.83% $0.00 318K Feb 13, 2024 Direct F1
transaction TLSI Common Stock Award $0 +125K +39.33% $0.00 443K Nov 24, 2025 Direct F2
transaction TLSI Common Stock Award $0 +300K +67.75% $0.00 743K Nov 24, 2025 Direct F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +250K +18.82% $0.00 1.58M Nov 24, 2025 Common Stock 250K $5.55 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the granting of Performance Stock Units (PSUs) upon achieving or exceeding $50 million of revenue over any 12 consecutive calendar month period ending on or before February 28, 2027. The PSUs vest immediately upon achieving the performance requirement, subject to the continued employment through each respective vesting date.
F2 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on November 24, 2025, subject to continued employment through the respective vesting date.
F3 Represents the granting of PSUs upon achieving or exceeding $75 million of revenue over any 12 consecutive calendar month period ending on or before December 31, 2027. 150,000 PSUs vest immediately upon achieving the performance requirement and 150,000 PSUs vest on the one-year anniversary of achieving the performance requirement, subject to the continued employment through each respective vesting date.
F4 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of November 24, 2025 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to continued employment through the respective vesting date.